LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -3.14%432.68M | 3.39%462.46M | 3.78%413.3M | 17.00%1.79B | 11.75%495.36M | 17.04%446.73M | 20.14%447.3M | 20.43%398.26M | 9.13%1.53B | 8.04%443.25M |
Operating revenue | -3.14%432.68M | 3.39%462.46M | 3.78%413.3M | 17.00%1.79B | 11.75%495.36M | 17.04%446.73M | 20.14%447.3M | 20.43%398.26M | 9.13%1.53B | 8.04%443.25M |
Cost of revenue | -1.20%225.22M | 2.54%239.43M | 0.42%217.77M | 9.53%935.51M | 4.54%257.17M | 7.38%227.97M | 12.31%233.5M | 15.41%216.86M | 8.83%854.12M | 5.97%246M |
Gross profit | -5.17%207.46M | 4.32%223.03M | 7.79%195.53M | 26.46%852.14M | 20.75%238.18M | 29.14%218.76M | 30.05%213.8M | 27.04%181.4M | 9.50%673.83M | 10.74%197.25M |
Operating expense | -6.71%111.81M | 8.74%122.15M | 3.52%110.07M | 17.37%464.63M | 19.56%126.13M | 23.35%119.86M | 10.84%112.33M | 15.71%106.32M | 1.34%395.88M | 3.25%105.49M |
Selling and administrative expenses | -6.92%95.1M | 9.07%105.08M | 3.36%94.15M | 17.05%396.65M | 16.99%107.04M | 23.47%102.18M | 11.92%96.34M | 15.96%91.09M | 1.81%338.87M | 5.75%91.49M |
Research and development costs | -5.51%16.71M | 6.74%17.07M | 4.51%15.92M | 19.25%67.99M | 36.35%19.08M | 22.66%17.68M | 4.74%15.99M | 14.24%15.23M | -1.35%57.01M | -10.54%14M |
Operating profit | -3.29%95.65M | -0.58%100.88M | 13.84%85.46M | 39.42%387.51M | 22.12%112.06M | 36.94%98.9M | 60.92%101.47M | 47.50%75.08M | 23.70%277.95M | 20.81%91.76M |
Net non-operating interest income expense | 26.76%-9.15M | 26.65%-9.66M | 6.41%-10.74M | -120.22%-38.55M | 58.17%-1.4M | -109.63%-12.5M | -187.79%-13.18M | -217.19%-11.48M | -133.34%-17.51M | -1,070.14%-3.35M |
Non-operating interest income | ---- | ---- | ---- | 96.97%8.18M | ---- | ---- | ---- | ---- | 27.61%4.16M | ---- |
Non-operating interest expense | -26.76%9.15M | -26.65%9.66M | -6.41%10.74M | 115.76%46.73M | 27.75%9.58M | 109.63%12.5M | 187.79%13.18M | 217.19%11.48M | 101.34%21.66M | 157.71%7.5M |
Other net income (expense) | 32.48%1.66M | 496.05%3.21M | 100.67%885K | -549.36%-142.27M | 41.24%-11.38M | 122.61%1.26M | -116.53%-810K | -6,856.36%-131.34M | 88.68%-21.91M | 88.28%-19.36M |
Gain on sale of security | -99.53%-2.99M | 119.39%603K | 44.12%-2.33M | -66.54%-17.08M | -51.78%-8.3M | 49.78%-1.5M | -312.58%-3.11M | -27.64%-4.18M | -4,647.69%-10.26M | -850.78%-5.47M |
Special income (charges) | 63.96%-1.18M | 53.94%-1.54M | 97.70%-3.02M | -877.03%-139.28M | 84.85%-1.68M | -265.41%-3.29M | -5,777.19%-3.35M | -5,882.55%-130.96M | 17.22%-14.26M | -122.98%-11.11M |
-Less:Restructuring and merger&acquisition | -63.96%1.18M | -53.94%1.54M | 72.70%3.02M | 24.19%9.89M | -68.67%1.51M | 265.41%3.29M | 5,777.19%3.35M | -20.19%1.75M | -51.53%7.97M | 14.90%4.82M |
-Less:Impairment of capital assets | ---- | ---- | ---- | -97.25%173K | ---- | ---- | ---- | ---- | 698.22%6.29M | ---- |
-Gain on sale of business | --0 | --0 | --0 | ---129.21M | --0 | --0 | --0 | ---129.21M | --0 | --0 |
Other non- operating income (expenses) | -3.38%5.83M | -26.58%4.15M | 64.21%6.24M | 441.60%14.09M | 49.87%-1.4M | 460.20%6.04M | 61.75%5.65M | 6.30%3.8M | 101.48%2.6M | 98.25%-2.79M |
Income before tax | 0.56%88.16M | 7.94%94.43M | 211.62%75.61M | -13.35%206.69M | 43.77%99.28M | 44.39%87.66M | 38.04%87.48M | -249.22%-67.74M | 910.56%238.53M | 177.64%69.05M |
Income tax | -4.00%21.51M | 8.83%22.19M | -78.81%17.47M | 151.44%148.11M | 30.21%22.87M | 41.77%22.41M | 30.02%20.39M | 736.74%82.44M | 3,143.56%58.9M | 163.95%17.56M |
Net income | 2.13%66.65M | 7.67%72.23M | 138.71%58.14M | -67.39%58.58M | 48.40%76.41M | 45.32%65.26M | 40.67%67.09M | -522.52%-150.17M | 724.44%179.63M | 183.75%51.49M |
Net income continuous Operations | 2.13%66.65M | 7.67%72.23M | 138.71%58.14M | -67.39%58.58M | 48.40%76.41M | 45.32%65.26M | 40.67%67.09M | -522.52%-150.17M | 724.44%179.63M | 183.75%51.49M |
Minority interest income | 0 | 0 | ||||||||
Net income attributable to the parent company | 2.13%66.65M | 7.67%72.23M | 138.71%58.14M | -67.39%58.58M | 48.40%76.41M | 45.32%65.26M | 40.67%67.09M | -522.52%-150.17M | 741.75%179.63M | 183.75%51.49M |
Preferred stock dividends | 0.00%10K | 0.00%10K | 0.00%10K | 0.00%41K | 0.00%11K | 0.00%10K | 0.00%10K | 0.00%10K | 0.00%41K | 0.00%11K |
Other preferred stock dividends | -25.00%6K | -25.00%6K | 7K | -13.33%26K | 11.11%10K | 0.00%8K | 0.00%8K | 0 | 25.00%30K | 1,000.00%9K |
Net income attributable to common stockholders | 2.14%66.63M | 7.67%72.22M | 138.70%58.12M | -67.41%58.52M | 48.42%76.39M | 45.34%65.24M | 40.69%67.07M | -522.72%-150.18M | 743.99%179.56M | 183.71%51.47M |
Basic earnings per share | 1.81%1.69 | 7.02%1.83 | 138.64%1.48 | -67.47%1.49 | 48.09%1.94 | 44.35%1.66 | 41.32%1.71 | -525.56%-3.83 | 748.15%4.58 | 183.44%1.31 |
Diluted earnings per share | 2.42%1.69 | 7.65%1.83 | 138.38%1.47 | -67.54%1.48 | 47.33%1.93 | 44.74%1.65 | 40.50%1.7 | -525.56%-3.83 | 744.44%4.56 | 183.44%1.31 |
Dividend per share | 8.51%0.51 | 8.51%0.51 | 2.17%0.47 | 2.75%1.87 | 2.17%0.47 | 2.17%0.47 | 2.17%0.47 | 4.55%0.46 | 4.00%1.82 | 4.55%0.46 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |